Journals / Uluslararası Hematoloji-Onkoloji Dergisi / 2014 / Cilt: 24 - Sayı: 1

Macrolide Treatment for Primary Immune Thrombocytopenia

Pages
65–66
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

OHE, M., HASHINO, S. (2014). Macrolide Treatment for Primary Immune Thrombocytopenia. Uluslararası Hematoloji-Onkoloji Dergisi, Cilt: 24 - Sayı: 1, 65–66. https://ajindex.com/articles/323164

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Ohe M, Kohno M. Three cases of idiopathic thrombocytopenic purpura showing an increase in the platelet count following clarithromycin treatment. Rinsho Ketsueki 44: 1044- 1046, 2003.
  2. Ohe M, Hashino S. Successful treatment with erythromycin for idiopathic thrombocytopenic purpura. Korean J Hematol 46: 139-142, 2011.
  3. Ohe M, Hashino S. Successful treatment of primary immune thrombocytopenia in aged patients using clarithromycin. J Formos Med Assoc 113: 197-198, 2014.
  4. Kuwana M, Ikeda Y. Helicobacter pylori and immune thrombocytopenic purpura: unresolved questions and controversies. Int J Hematol 84: 309-315, 2006.
  5. Otsu K, Ishinaga H, Suzuki S, et al. Effects of a novel nonantibiotic macrolide, EM900, on cytokine and mucin gene expression in a human airway epithelial cell line. Pharmacol 88: 321-332, 2011.